FAKTOR OPTIONSSCHEIN - AMGEN | Market Closed - BOERSE MUENCHEN 14:26:45 2024-05-24 EDT | ||
| 2.31 EUR | -7.23% |
|
| Current month | +81.60% | ||
| 1 month | +77.28% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
| Date | Price | Change |
|---|---|---|
| 24-05-24 | 2.31 | -7.23% |
| 24-05-23 | 2.49 | -13.24% |
| 24-05-22 | 2.87 | -3.04% |
| 24-05-21 | 2.96 | -2.31% |
| 24-05-20 | 3.03 | +5.94% |
Real-time BOERSE MUENCHEN
Last update May 24, 2024 at 02:26 pm
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | Goldman Sachs |
| WKN | GZ8NQH |
| ISIN | DE000GZ8NQH9 |
| Date issued | 2023-02-14 |
| Strike | 278.5 $ |
| Maturity | Unlimited |
| Parity | 12.23 : 1 |
| Emission price | 8.75 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 13.46 € |
|---|---|
| Lowest since issue | 0.9 € |
| Spread | 0.03 € |
| Spread % | 1.31% |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
305.8
USD
Average target price
316.3
USD
Spread / Average Target
+3.41%
- Stock Market
- Certificates
- Certificat
